"After the new production line of xinyi pharmaceutical factory was officially put into operation, the sales of the national first-class biological products Produced by Peficon were very good, with sales of seven or eight hundred million yuan a year..."
"We had another batch of new drugs approved last year. One of the super Duffy models can eliminate the flu virus in 72 hours compared to the traditional Tamiflu, the time is shortened to 24 hours, and it was approved to enter the medical insurance in the same year, which makes us very encouraged..."
Zhangjiang is the main front of Shanghai's construction of a science and technology innovation center with global influence, and a large number of science and technology innovation enterprises have gathered. On the morning of January 19, Hang Yingwei, mayor of Pudong New Area, together with the main leaders of the District Science and Economic Commission, the Construction and Communications Commission, the Emergency Management Bureau, the Fire Detachment and other departments, visited three of the key enterprises. Everywhere they go, before they can say a few words, companies can't help but share exciting good news.
However, behind the good news, there is also the "happiness trouble" of the enterprise.
On the last day of last year, the nearly 30,000-square-meter Shanghai Pharmaceutical Biomedical Industry Base Project successfully completed the pouring project of the large floor. The project aims to build an incubation and transformation base and industrialization platform with a complete layout and leading technology in the domestic biomedical sector around the biomedical innovation fields such as therapeutic antibodies, cell therapy, and gene therapy, and is scheduled to be completed and put into operation in 2023.
After completion, not only the Shanghai Biomedical Frontier Innovation Center will come here to work, but other top global biomedical companies also plan to open innovation incubation centers here.
"It is good to be able to promote the opening of the platform to more large, medium, and small enterprises, and promote industrial integration and innovation." What difficulties do you have? The district leader asked.
Zhou Jun, chairman of Shanghai Pharmaceutical, immediately raised two issues related to land use. One is the expansion of the Xinyi Pharmaceutical Factory, which produces Peifikang. "At present, due to the planning of the surrounding land, there is some resistance when declaring. But our drug market response is so good, I really want to take advantage of the chase and increase investment..."
Listening to the "happiness troubles" brought about by the good development momentum of the enterprise, Hang Yingwei hurriedly turned to the responsible comrades of the Science and Technology Economic Commission and the Construction and Communications Commission: "After this problem goes back, we will pay close attention to docking." Subsequently, he asked in detail about the specific location of the project that the company is currently investing in In Pudong.
The pharmaceutical industry has ushered in an explosive period in recent years, especially with the continuous acceleration of the listing process of new drugs, many pharmaceutical companies in Zhangjiang have the intention of expanding capacity and increasing capital. However, if a company wants to invest in a region for a long time, whether the region can bring more stable policy expectations to enterprises is the key. When the Pudong New Area Government visited Roche Pharmaceutical, Bian Xin, president of China, raised an issue of common concern to market players:
"During the '13th Five-Year Plan' period, we received tax policy support from Shanghai and Pudong, and our development is improving. After entering the 14th Five-Year Plan, it is still unclear whether we can still enjoy these policies. In addition, we have two companies, registered in different sectors of Pudong New Area, there are also certain differences in the policies that can be enjoyed, is there any way to crack? ”
Roche Pharmaceutical is the first Sino-foreign joint venture to settle in Zhangjiang, which has been deeply cultivating Pudong for nearly 30 years, and the industrial output value will reach 12.5 billion yuan in 2021. In recent years, Roche Pharmaceutical has also been increasing its R&D investment in China, successively building a new R&D center and establishing a large enterprise open innovation center. In the face of the demands of enterprises, Hang Yingwei immediately said that the policy must be sustainable and stable, so that enterprises can invest with confidence. "Our relevant departments will definitely arrange corresponding policy guidance for enterprises as soon as possible, and the policy directly to enterprises is the most important!"
Roche's innovative drug portfolio.
In the process of "promoting development and ensuring safety" and the large-scale inspection, the Pudong New Area Government asked especially carefully about the production safety of enterprises.
When walking to Shenglian Precision Gas (Shanghai) Co., Ltd. to inspect the compressed gas production and storage equipment, the district leader specially went forward to touch one of the pipes with frost on the surface, "Is there a leak around this?" “
General Manager Tang Ruiping immediately transformed into a "Koppda": "This is not a leak, it is a cold air emitted by low temperatures around the pipeline, just like the aerosol after the refrigerator freezer is opened." ”
Shenglian Precision Gas has been in Zhangjiang since 2002, mainly engaged in the production and operation of high-purity gases and special gases for the electronics industry. A few years ago, a large customer of the company expanded production, which led to the expansion of Shenglian Precision Gases. Today, the company has a set of 35,000Nm³/h air separation nitrogen production equipment and supporting facilities, a hydrogen room, 4 liquefied gas storage tanks and their vaporizers, and the equipment group looks very spectacular.
Shenglian precision gas large equipment.
The leaders of Pudong New Area understood the situation of several equipment one by one, and repeatedly instructed the person in charge of the safety supervision department around them: "We must grasp the risks and escort the development of the enterprise." ”
Not long ago, Roche Pharmaceutical made a set of corporate plans for epidemic prevention and control. The leaders of Pudong New Area frequently nodded after listening to it, and added: "According to our past experience, we can also provide you with a little 'small advice': prepare more tables, chairs, benches, camp beds and other materials, which can be of great use at critical times." Everyone works together to coordinate the relationship between development and security, and only when the enterprise is good can the region be good. ”
Column Editor-in-Chief: Xu Min Text Editor: Du Chenwei
Source: Author: Du Chenwei